Loading insider details...
Beta
Latest Form 4 (Jul 21, 2026): Grant/Award of 136 ARTL shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 21, 2026 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 136 | n/a |
| Jun 18, 2026 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/Award | 30,000 | n/a |
| Feb 2, 2026 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 292 | n/a |
| Oct 31, 2025 | ARTELO BIOSCIENCES, INC. (ARTL) | Conversion | 6,846 | n/a |
| Sep 16, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Purchase | 3,175 | $24.7K |
| May 31, 2025 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/Award | 30,000 | n/a |
| Dec 23, 2024 | ARTELO BIOSCIENCES, INC. (ARTL) | Grant/Award | 1,750 | n/a |
| May 16, 2024 | ZEVRA THERAPEUTICS, INC. (ZVRA) | Grant/Award | 49,200 | n/a |
| Mar 2, 2024 | ARTELO BIOSCIENCES, INC. (ARTL) | Disposition to Issuer | 2,000 | n/a |
| Sep 1, 2023 | Kintara Therapeutics, Inc. (KTRA) | Grant/Award | 8,500 | n/a |